BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Man S, Luo C, Yan M, Zhao G, Ma L, Gao W. Treatment for liver cancer: From sorafenib to natural products. Eur J Med Chem 2021;224:113690. [PMID: 34256124 DOI: 10.1016/j.ejmech.2021.113690] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Shao M, Wang Y, Dong H, Wang L, Zhang X, Han X, Sang X, Bao Y, Peng M, Cao G. From liver fibrosis to hepatocarcinogenesis: Role of excessive liver H2O2 and targeting nanotherapeutics. Bioactive Materials 2023;23:187-205. [DOI: 10.1016/j.bioactmat.2022.11.001] [Reference Citation Analysis]
2 Alarif WM, Baamer DF, Ghandourah MA, Alorfi HS, Alburae NA, Budiyanto F, Abdel-Naim AB. The pro-apoptotic activity of sinueracasbanone D isolated from Sinularia Leptoclados in hepatocellular carcinoma cells. Environ Sci Pollut Res Int 2023. [PMID: 36930304 DOI: 10.1007/s11356-023-26466-8] [Reference Citation Analysis]
3 Li S, Zhang H, Liu J, Shang G. Targeted therapy for osteosarcoma: a review. J Cancer Res Clin Oncol 2023. [PMID: 36807762 DOI: 10.1007/s00432-023-04614-4] [Reference Citation Analysis]
4 Tang L, Zhang Y, Xu J, Yang Q, Du F, Wu X, Li M, Shen J, Deng S, Zhao Y, Xiao Z, Chen Y. Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities. Molecules 2023;28. [PMID: 36771080 DOI: 10.3390/molecules28031414] [Reference Citation Analysis]
5 Wang YX, Jin YY, Wang J, Zhao ZC, Xue KW, Xiong H, Che HL, Ge YJ, Wu GS. Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition. Molecules 2023;28. [PMID: 36770781 DOI: 10.3390/molecules28031109] [Reference Citation Analysis]
6 Lai Q, Yang CJ, Zhang Q, Zhuang M, Ma YH, Lin CY, Zeng GZ, Yin JL. Alkaloid from Alstonia yunnanensis diels root against gastrointestinal cancer: Acetoxytabernosine inhibits apoptosis in hepatocellular carcinoma cells. Front Pharmacol 2022;13:1085309. [PMID: 36712668 DOI: 10.3389/fphar.2022.1085309] [Reference Citation Analysis]
7 Wang L, Xu X, Chen D, Li C. Dihydrotanshinone I inhibits hepatocellular carcinoma cells proliferation through DNA damage and EGFR pathway. PeerJ 2023;11:e15022. [PMID: 36935927 DOI: 10.7717/peerj.15022] [Reference Citation Analysis]
8 Chen C, Liang T, Wu Q, Zhou Z, Zhang M, Feng D, Tao J, Si T, Cai M. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma. Comput Math Methods Med 2022;2022:2940654. [PMID: 36578460 DOI: 10.1155/2022/2940654] [Reference Citation Analysis]
9 Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1051998] [Reference Citation Analysis]
10 Kim DB, Lee DK, Cheon C, Ribeiro RIMA, Kim B. Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. Nutrients 2022;14:4252. [DOI: 10.3390/nu14204252] [Reference Citation Analysis]
11 Zhang Y, Ren H, Zhang C, Li H, Guo Q, Xu H, Cui L. Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma. Front Immunol 2022;13:1028054. [DOI: 10.3389/fimmu.2022.1028054] [Reference Citation Analysis]
12 Gao S, Jiang X, Wang L, Jiang S, Luo H, Chen Y, Peng C. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Front Pharmacol 2022;13:1029601. [DOI: 10.3389/fphar.2022.1029601] [Reference Citation Analysis]
13 Sufianova G, Gareev I, Beylerli O, Wu J, Shumadalova A, Sufianov A, Chen X, Zhao S. Modern aspects of the use of natural polyphenols in tumor prevention and therapy. Front Cell Dev Biol 2022;10:1011435. [DOI: 10.3389/fcell.2022.1011435] [Reference Citation Analysis]
14 Wu Y, Chang J, Ge J, Xu K, Zhou Q, Zhang X, Zhu N, Hu M. Isobavachalcone's Alleviation of Pyroptosis Contributes to Enhanced Apoptosis in Glioblastoma: Possible Involvement of NLRP3. Mol Neurobiol 2022. [PMID: 36053436 DOI: 10.1007/s12035-022-03010-2] [Reference Citation Analysis]
15 Ma L, Liu T, Lu Y, Dong Y, Zhao X, Man S. A natural halogenated fluoride adenosine analog 5'-fluorodeoxy adenosine induced anticolon cancer activity in vivo and in vitro. Environ Toxicol 2022. [PMID: 35866996 DOI: 10.1002/tox.23612] [Reference Citation Analysis]
16 Muhammad N, Usmani D, Tarique M, Naz H, Ashraf M, Raliya R, Tabrez S, Zughaibi TA, Alsaieedi A, Hakeem IJ, Suhail M. The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer. Cells 2022;11:2209. [PMID: 35883653 DOI: 10.3390/cells11142209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wang J, Chang H, Su M, Zhao H, Qiao Y, Wang Y, Shang L, Shan C, Zhang S. The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology. Front Pharmacol 2022;13:934729. [DOI: 10.3389/fphar.2022.934729] [Reference Citation Analysis]
18 Yu C, Lee H, Yang S, Wang S, Lin C, Hsieh Y, Chiou H. Protodioscin Induces Mitochondrial Apoptosis of Human Hepatocellular Carcinoma Cells Through Eliciting ER Stress-Mediated IP3R Targeting Mfn1/Bak Expression. JHC 2022;Volume 9:327-41. [DOI: 10.2147/jhc.s355027] [Reference Citation Analysis]
19 Zou X, Tang XY, Qu ZY, Sun ZW, Ji CF, Li YJ, Guo SD. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review. Int J Biol Macromol 2022;202:539-57. [PMID: 35074329 DOI: 10.1016/j.ijbiomac.2022.01.113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
20 Hu J, Jiang J, Liu R, Cheng M, Zhu G, He S, Shi B, Zhao Y, He Z, Yu H, Zhang X, Zheng H, Hua B. Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:828450. [PMID: 35280766 DOI: 10.3389/fonc.2022.828450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li W, Pei S, Zhang X, Qi D, Zhang W, Dou Y, Yang R, Yao X, Zhang Z, Xie S, Fang D, Sun H. Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zheng Y, Zhang W, Xu L, Zhou H, Yuan M, Xu H. Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer. Front Oncol 2021;11:795548. [PMID: 35155196 DOI: 10.3389/fonc.2021.795548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
23 Ye Z, Zhang X, Zhang Y, Liu L, Xuan Z, Huang P. Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma. Front Oncol 2022;12:761021. [DOI: 10.3389/fonc.2022.761021] [Reference Citation Analysis]
24 Savier E, Simon-Gracia L, Charlotte F, Tuffery P, Teesalu T, Scatton O, Rebollo A. Bi-Functional Peptides as a New Therapeutic Tool for Hepatocellular Carcinoma. Pharmaceutics 2021;13:1631. [PMID: 34683924 DOI: 10.3390/pharmaceutics13101631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]